Page 2 - Carnot

Accelerate the Target Markets

time-to-market of Diagnostic tests

Vaccines
therapeutic, Anti-infectives
Medical biotechnology
diagnostic, Innovative medical devices
Technologies for life sciences

vaccine and Artificial intelligence
Innovations in the food
biotechnological industry
Probiotics

solutions Alicaments

Interdisciplinarity and State-of-the-art technologies

integrative approach Innovative technologies applied to biology,
such as chemogenomic screening, imaging and
The action of the institut Carnot Pasteur MS is microfluidics, are sources of innovation that open
structured around 4 themes, of which each forms up new perspectives in biomedical research, in
a continuum between fundamental research and particular the identification of new biomarkers or
applications of research:
therapeutic targets. This is why several units and
technological platforms are also part of the institut

Emerging infectious diseases Carnot Pasteur Microbes & Santé.
Antimicrobial resistance

Microbiota and non-communicable diseases
Interface with maths, physics and chemistry

Its scope consists of six Institut Pasteur departments
that primarily deal with infectious diseases
Cell Biology and Infection / Global Health /
Microbiology / Parasites and Insect Vectors /
Virology / Mycology in association with several
immunology, neuroscience, structural biology and
chemistry units.
Interdisciplinarity is key to finding new therapeutic
and diagnostic strategies, particularly for diseases
involving the immune system (chronic infection,
autoimmune diseases) or of neurodegenerative
and cerebral origin (Alzheimer’s and Parkinson’s in
particular).